Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
NCT Number: NCT03044340
Erythromelalgy (EM) is a vascular syndrome very rare affecting the feet. This disease evolve by crisis when the feet extremities become red hot and painful. There are several types of EM but this study concern the adult primitive form. For a long time, the physiopathology was not described but now we know that there is a vascular form, with microcirculatory dysfunction and a neurologic form with small fibers neuropathy. The diagnostic of neurologic form is based on clinical evaluation (DN4 questionnaire, UENS scale...) and an electromyography. Thermotest, a medical device which measure the thermic sensitivity is used to quantify neuropathy. More recently Sudoscan, a device measuring cutaneous impedance to chloride ions detect small nervous fiber in diabetic patients with good correlation with Thermotest.
The purpose of this study is to analyze the vascular side and the neurologic side on patients consulting for Erythromelalgy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, Île-de-France Region, 75014, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Measurement of chlorine ions impedance by SUDOSCAN and pain due to temperature evaluation with THERMOTEST
Time frame: Day1
patient will be measured the impedance of chlorinates ions by Sudoscan
Time frame: Day1
Patients will be measured their sensitivity to temperature changing using the Thermotest
Fondation Hôpital Saint-Joseph
Other
Vascular and Neurologic Exploration of Small Nervous Fiber by Sudoscanner
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05917912
Cardiovascular Diseases, Erythromelalgia
Rochester, Minnesota, United States
View Trial DetailsNCT02214615
Cardiovascular Diseases, Erythromelalgia
New Haven, Connecticut, United States
View Trial DetailsNCT01486446
Cardiovascular Diseases, Erythromelalgia
Anniston, Alabama, United States
View Trial DetailsNCT01090622
Cardiovascular Diseases, Erythromelalgia
Nijmegen, Netherlands
View Trial Details